// App-Quantinova.ai

P1457 : DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES

Researchers

Presenter

  • Sylvain Choquet

Principal Investigators

  • Ben Uttenthal

  • Sridhar Chaganti

  • Patrizia Comoli

  • Ralf Trappe

  • Anke Friedetzky

  • Baodong Xing

  • Xiaoming Li

  • Tobias Polak

  • Laurence Gamelin

  • Jan-Henrik Terwey

  • Daan Dierickx

Medical Centers

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Hématologie clinique,Sorbonne Université, Hôpital de la Pitié-Salpêtrière,Paris,France

  • Atara Biotherapeutics,Thousand Oaks,United States

  • Department of Haematology,Cambridge University Teaching Hospit

  • Atara Biotherapeutics, Thousand Oaks, CA

  • Department of Haematology,Cambridge University Teaching Hospitals NHS Foundation Trust,Cambridge,Regno Unito

  • Atara Biotherapeutics,Thousand Oaks,États-unis

  • Atara Biotherapeutics,Thousand Oaks,United States

  • DIAKO Evange

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Department of Haematology,Queen Elizabeth Hospital,Birmingham,Regno Unito

  • Epidemiology,ErasmusMC,Rotterdam,Pays-bas

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Histopathology, Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Department of Haematology,Cambridge University Teaching Hospitals NHS Foundation Trust,Cambridge,Regno Unito

  • Hématologie clinique,Sorbonne Université, Hôpital de la Pitié-Salpêtrière,Paris,France

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Atara Biotherapeutics,Thousand Oaks,États-unis

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Atara Biotherapeutics,Zug,Швейцария

  • Hématologie clinique,Sorbonne Université, Hôpit

  • Biostatistics &amp

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Atara Biotherapeutics,Thousand Oaks,États-unis

  • Department of Haematology,Queen Elizabeth Hospital,Birmingham,Regno Unito

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Department of Haematology,Queen Elizabeth Hospital,Birmingham,Regno Unito

  • Epidemiology,ErasmusMC,Rotterdam,Paesi Bassi

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Cell Factory and Pediatric Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Oncology,Erasmus MC,Rotterdam,Niederlande

  • Cell Factory and Pediatric Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Hématologie clinique,Sorbonne Université, Hôpital de la Pitié-Salpêtrière,Paris,France

  • Department of Haematology,Queen Elizabeth Hospital,Birmingham,Regno Unito

  • Cell Factory and Pediatric Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Epidemiology,ErasmusMC,Rotterdam,N

  • Atara Biotherapeutics,Thousand Oaks,United States

  • Epidemiology,ErasmusMC,Rotterdam,Pays-bas

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Cell Factory and Pediatric Hematolog

  • Department of Haematology,Cambridge University Teaching Hospitals NHS Foundation Trust,Cambridge,Vereinigtes Königreich

  • Cell Factory and Pediatric Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • DIAKO Evangelisches Diakonie-Krankenhaus Bremen,Bremen,Duitsland

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

Locations

  • France

  • United States

  • United Kingdom

  • Italy

  • Germany

  • Switzerland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Post-transplant lymphoproliferative disorder

Biomarkers

  • Hematocrit

Drug/Treatment

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT04554914

  • NCT03394365

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved